Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CerbB2 status in breast cancer: pathologic issues.

Annals of the Academy of Medicine, Singapore - 1 Nov 2002

Lian S C, Tan P H

Abstract excerpt

INTRODUCTION: CerbB2 status determination in breast cancer is currently performed for predictive and prognostic information. However, much has yet to be learned about the accuracy, reproducibility and clinical correlation of the different testing methods available today. This is a review of the testing methods commonly in use and their applications in the management of breast cancer. METHODS: A Medline search for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy, Needle
Share to Gene Amplification
Share to Genes, erbB-2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to In Situ Hybridization, Fluorescence

Share to Neoplasm Staging

Share to Predictive Value of Tests

Share to Sensitivity and Specificity

Share to Survival Rate

Source

Identifiers

PMID: 12520836

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CerbB2 status in breast cancer: pathologic issues.PMID 12520836Read ↗

Molecular genetics of solid tumours: translating research into clinical practice. What we could do now: breast cancer.Semantic proximity Read ↗

[Clinically relevant molecular pathological diagnostics in breast cancer].Semantic proximity Read ↗

[Expression of epidermal growth factor receptor-2 in Chinese breast cancer patients: a meta-analysis].Semantic proximity Read ↗

Biomarker assessment and molecular testing for prognostication in breast cancerSemantic proximity Read ↗

Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic ConsiderationsSemantic proximity Read ↗

Evaluation of analytical accuracy of HER2 status in patients with breast cancerSemantic proximity Read ↗

Single HER2-Positive Tumor Cells are Detected in Initially HER2-Negative Breast Carcinomas using the DEPArray™–HER2-FISH WorkflowSemantic proximity Read ↗

Assessing the New American Society of Clinical Oncology/College of American Pathologists Guidelines for HER2 Testing by Fluorescence In Situ Hybridization: Experience of an Academic Consultation PracticeSemantic proximity Read ↗

Detection of HER2 Status in Breast Cancer: Comparison of Current Methods with MLPA and Real-time RT-PCRSemantic proximity Read ↗

Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplificationSemantic proximity Read ↗

Determination of Hormone Receptors, Human Epidermal Growth Factor Receptor 2 and Ki67 Status in Invasive Breast Carcinoma: A Concordance Study between Immunohistochemistry, Fluorescence in Situ Hybridization, and GeneXpert® Breast Cancer STRAT4 AssaySemantic proximity Read ↗

HER-2/neu diagnostics in breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.